The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Methylene Blue in Vasoplegic and Refractory Septic Shock

Rescue therapy acting as a guanylate-cyclase inhibitor in vasoplegia unresponsive to high-dose vasopressors.

Written by: Saygı Hospital Health Guide Editorial Board
Published: · Last updated:

This content is for general information; please consult your physician for diagnosis and treatment.

References (2)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kardiyoloji department. Book Appointment →

What is Methylene Blue in Vasoplegic and Refractory Septic Shock?

Methylene blue (MB) is a thiazine-class dye with multiple pharmacological actions: guanylate-cyclase inhibition (blocking the NO/cGMP pathway), MAO-A inhibition (affecting serotonin reuptake), and methemoglobinemia treatment (as a reductant).

Use in vasoplegic syndrome (post-cardiopulmonary bypass, septic shock, anaphylaxis, or severe hypotension in ARDS): excessive nitric-oxide (NO) production raises cGMP, relaxes vascular smooth muscle, and leads to persistent hypotension despite high-dose norepinephrine, vasopressin, and epinephrine. MB blocks cGMP synthesis and restores vascular tone.

Dosing — 1-2 mg/kg IV slow infusion (20-60 min), repeated every 4-6 hours if needed, or a continuous infusion of 0.25-1 mg/kg/hour (total daily dose should not exceed 7 mg/kg). Effect begins within minutes, typically reducing vasopressor requirements by 30-50%.

Current evidence — Grade 2C recommendation for post-cardiac-surgery vasoplegia (small RCTs); used only as rescue in septic shock, not routinely recommended by Surviving Sepsis Campaign. The CLASSIC trial (2024) and ongoing studies continue to refine the indications.

Symptoms

Refractory vasoplegic shock — norepinephrine >0.5 mcg/kg/min + vasopressin 0.03 U/min + epinephrine with MAP <65
Post-cardiopulmonary-bypass vasoplegia — SIRS resembling sepsis with low SVR (<800)
Anaphylactic shock — persistent shock despite IV fluids + epinephrine + vasopressor
Hemodynamic instability in ARDS (reflecting NO-mediated pulmonary vasodilation)
Methemoglobinemia — SpO2/PaO2 discordance and cyanosis unresponsive to IV fluids and O2 (routine and accepted indication)

Risk Factors

Concurrent SSRI or MAOI — life-threatening serotonin-syndrome risk
G6PD deficiency — MB can precipitate hemolytic anemia (especially at doses >7 mg/kg/day)
Renal failure — urine turns blue (harmless), but toxicity risk rises at high doses
Pulmonary hypertension — blocking NO/cGMP may increase PVR and worsen right-heart failure
Paradoxical methemoglobinemia — high-dose MB itself can induce methemoglobinemia

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Post-cardiopulmonary-bypass MAP <65 unresponsive to high-dose vasopressors (norepinephrine + vasopressin)
  • Septic shock — resistant after maximal vasopressors + steroid; echocardiogram shows preserved EF with very low SVR
  • Anaphylaxis — refractory hypotension despite IV epinephrine + vasopressor + fluids

Treatment Methods

01
Indication assessment — echocardiogram showing preserved EF + low SVR + high-dose vasopressor; screen for SSRI/MAOI; estimate G6PD risk
02
Dosing — 1-2 mg/kg IV slow infusion (20-60 min). Response expected within 15-30 minutes (rising MAP, ability to wean vasopressors)
03
If needed, repeat every 4-6 hours or run a continuous infusion of 0.25-1 mg/kg/hour (up to 7 mg/kg/day)
04
Monitoring — arterial pressure, SaO2 (MB can falsely lower pulse-oximetry — rely on blood-gas analysis), vasopressor titration, and serotonin-syndrome signs (fever, tremor, mental changes)
05
Combined therapy — fluids, corticosteroid (hydrocortisone), vasopressor titration, and underlying cause management (antibiotics for sepsis; reoperation consideration for bypass)
06
Cautions — urine and perspiration turn blue (normal), pulse oximeter reads falsely low (use PaO2 as reference), avoid confusion with MRI contrast agents

Which Department to Visit?

You can visit our Kardiyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kardiyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Hypertension (High Blood Pressure)

Kardiyoloji

Hypertension is a condition in which blood pressure readings remain above 140/90 mmHg; early treatment helps prevent serious complications.

Coronary Artery Disease

Kardiyoloji

Narrowing of the coronary arteries due to atherosclerosis can cause chest pain (angina) and heart attack.

Heart Failure

Kardiyoloji

Heart failure is a chronic cardiac condition characterized by shortness of breath, leg swelling, and fatigue.

Heart Attack (Myocardial Infarction)

Kardiyoloji

A heart attack is a medical emergency; because heart muscle is lost by the minute, immediate intervention saves lives.

Atrial Fibrillation

Kardiyoloji

Atrial fibrillation is a common arrhythmia characterized by an irregular heartbeat and increased risk of stroke.

Heart Palpitations

Kardiyoloji

Palpitations are usually due to benign causes, but underlying cardiac rhythm disorders must be ruled out.

Heart Valve Diseases

Kardiyoloji

Valve stenosis or regurgitation increases the workload of the heart and, over time, can lead to heart failure.

Aortic Aneurysm

Kardiyoloji

Aortic aneurysms are often silent; early diagnosis allows treatment before rupture (a life-threatening tear).

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.